Importance of intrathecal pain therapy;Stellenwert der intrathekalen schmerztherapie

Schmerz

Volumn 21, Issue 1, 2007, Pages 15-27

  Likar, R ^a   Ilias, W ^b   Kloimstein, H ^c   Kofler, A ^d   Kress, H G ^e   Neuhold, J ^f   Pinter, M M ^g   Spendel, M C ^a  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

^b KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^c KEPLER UNIVERSITY HOSPITAL   (Austria)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f ELISABETHINEN HOSPITAL   (Austria)

^g Neurologisches Zentrum Rosenhugel   (Austria)

Author keywords

Chronic pain; Intrathecal drug delivery; Opioids; Pain pump; Spasticity

Indexed keywords

ANALGESIC AGENT; OPIATE;

ANALGESIA; CATHETER; CHRONIC PAIN; CONSERVATIVE TREATMENT; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; HUMAN; MINIPUMP; NONHUMAN; PATIENT CARE; PATIENT SELECTION; QUALITY OF LIFE; REVIEW; SPASTICITY; TREATMENT OUTCOME;

ANALGESIA, EPIDURAL; ANALGESICS, OPIOID; ANIMALS; CHRONIC DISEASE; HUMANS; INFUSION PUMPS, IMPLANTABLE; MUSCLE SPASTICITY; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE;

EID: 33847189952     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-006-0515-2     Document Type: Review

References (40)

1. Anderson V et al. (2003) A prospective, randomized trial of intrathecal injection vs. epidural infusion in the selection of patients for continuous intrathecal opioid therapy. Neuromodulation 6(3): 142-152
2. Bedder MD, Burchiel K (1991) Cost analysis of two implantable narcotic delivery systems. J Pain Symptom Manage 6: 368-373
3. Bejjani GK, Karim NO, Tzortzidis F (1997) Intrathecal granuloma after implantation of a morphine pump: case report and review of the literature. Surg Neurol 48: 288-291
4. Benedetti C (1987) Intraspinal analgesia: a historical overview. Acta Anaesthesiol Scand 31(85): 17-24
5. Bennett G et al. (2000) First Polyanalgesic Consensus Conference: evidence-based review of the literature on intrathecal pain medication. J Pain Symptom Manage 20(2): 12-36
6. Bennett G et al. (2000) Clinical guidelines for intrathecal pain therapy. J Pain Symptom Manage 20(2): 37-43
7. Bennett G et al. (2000) Future directions in the management of pain by intrathecal drug delivery. J Pain Symptom Manage 20(2): 44-50
8. Blount JP, Remley KB, Yue SK, EricksonDL (1996) Intrathecal granuloma complicating chronic spinal infusion of morphine. Report of three cases. J Neurosurg 84: 272-276
9. Buchser E et al. (2004) Efficacy of Intrathecal Bupivacaine: How Important Is the Flow Rate? Pain Med 5, 3:248-252
10. Cabbell KL et al. (1998) Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case reports. Neurosurgery 42: 1176-1180
11. Coffey R, Burchiel K (2002) Inflammatory mass lesions associated with intrathecal drug infusion catheters. Neurosurgery 50: 78-86
12. Deer T et al. (2004) Intrathecal drug delivery for treatment of chronic low back pain: report from the National Outcomes Registry for Low Back Pain. Pain Med 5(1): 6-13
13. Deer T et al. (1999) Intrathecal therapy for cancer and nonmalignant pain: patient selection and patient management. Neuromodulation 2(2): 55-66
14. Follett K et al. (2004) Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology 100(6): 1582-1594
15. Follett K et al. (2004) Prevention of intrathecal drug delivery catheter-related complications. Neuromodulation 6(1): 32-41
16. Follett K. et al. (2002) Selection of candidates for intrathecal drug administration to treat chronic pain: considerations in pre-implantation trials. Medtronic: 2-19
17. Hassenbusch SJ et al. (2000) Current practice In intraspinal pain therapy. J Pain Symptom Manage 20(2): 4-11
18. Hassenbusch SJ et al. (2004) Polyanalgesic Consensus Conference 2003: an update on the management of pain by Intraspinal drug delivery. Report of an expert panel. J Pain Symptom Manage 27(6): 540-563
19. Hildebrand K et al. (2001) Stability, compatibility, and safety of intrathecal bupivacaine administered chronically via an implantable delivery system. Clin J Pain 17: 239-244
20. Jain KK (2000) An evaluation of intrathecal ziconotide for the treatment of chronic pain. Expert Opin Investig Drugs 9: 2403-2410
21. Kumar K et al. (2002) Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: a cost-effectiveness analysis. J Neurosurg 97(10): 803-810
22. Lamer TJ (1994) Treatment of cancer-related pain when orally administered medications fail. Mayo Clinic Proc: 373-480
23. Langsam A (1999) Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report. Neurosurgery 44: 689-691
24. Maeyaert J et al. (2003) Patient-controlled analgesia in intrathecal therapy for chronic pain: safety and effective operation of the model 8831 Personal Therapy Manager with a pre-implanted SynchroMed infusion system. Neuromodulation 6: 133-141
25. McMillan M et al. (2003) Catheter-associated masses in patients receiving intrathecal analgesic therapy. Anesth Analg 96: 186-190
26. Njee T et al. (2004) Intrathecal morphine infusion for chronic non-malignant pain: a multiple center retrospective survey. Neuromodulation 7(4): 249-259
27. North RB, Cutchis PN, Epstein JA, Long DM (1991) Spinal cord compression complicating subarachnoid infusion of morphine: case report and laboratory experience. Neurosurgery 29(5): 778-784
28. Österreichische Schmerzgesellschaft (2003) Konsensus-Statement: Aktive Teilnahme des Opioidbehandelten Schmerzpatienten am Straßenverkehr. Schmerz Nachrichten 1: I-VIII
29. Paice JA, Penn RD, Shott S (1996) Intraspinal morphine for chronic pain: a retrospective, mulitcenter study. J Pain Symptom Manage 11: 71-80
30. Rainov N et al. (2002) Making a case for programmable pumps over fixed rate pumps for the mangement of fluctuations in chronic pain and spasticity: a literature review. Neuromodulation 5(2): 89-99
31. Smith T et al. (2005) An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). Ann Oncol 16: 825-833
32. Smith T et al. (2004) Pain management, including intrathecal pumps. Curr Oncol Rep 6: 291-296
33. Staats PS et al. (2004) Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlles trial. JAMA 291: 63-70
34. Turner M (2003) Intrathecal drug delivery 2002. Acta Neurochir 87: 29-35
35. Tutak U, Doleys DM (1996) Intrathecal infusion systems for treatment of chronic low back and leg pain of noncancer origin South Med J 89: 295-300
36. Winkelmüller M, Winkelmüller W (1991) Intrathekale Opiattherapie bei chronischen Schmerzsyndromen benigner Ätiologie über implantierbare Medikamentenpumpen. Schmerz 5: 28-36
37. Winkelmüller M, Winkelmüller W (1996) Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 85: 458-467
38. Yaksh TL (1976) Analgesia mediated by a direct spinal action of narcotics. Science 192: 1357-1358
39. Yaksh TL (1999) Spinal systems and pain processing, development of novel analgesic drugs with mechanistically defined models. Trends Pharmacol Sci 20(8): 329-337
40. Zenz M, Jurna I (1993) Lehrbuch der Schmerztherapie. Wissenschaftliche Verlagsgesellschaft, Stuttgart